Pharmaceutical Supply – Hydrochlorothiazide Tablets

The contract entails the supply of Hydrochlorothiazide Tablets, USP, formulated and packaged to meet federal pharmaceutical standards and specific military packaging requirements, ensuring compatibility with Department of Defense logistical and storage protocols. The product must be delivered in compliant bottles suitable for institutional use within military medical facilities, adhering to rigorous quality, labeling, and stability controls dictated by federal regulations and defense supply chain specifications. This subcontract is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, solicited by the Medical Supply Chain Pharm FSA under the Department of Defense. The opportunity was posted on May 13, 2026, with a firm response deadline of May 19, 2026. Performance is focused on FPO, ZIP 09583, indicating delivery to U.S. military postal addresses overseas or in transit. The solicitation is accessible via a designated DIBBS portal link and requires bidders to comply with all federal and defense-specific pharmaceutical procurement rules without any set-aside provisions specified.